Rezultaty - Johann S. de Bono

Redukuj rezultaty
  1. 1
    Translating Scientific Advancement into Clinical Benefit for Castration-Resistant Prostate Cancer Patients

    Translating Scientific Advancement into Clinical Benefit for Castration-Resistant Prostate Cancer Patients od Gerhardt Attard, Johann S. de Bono

    Wydane 2011
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  2. 2
    Treatment of Advanced Prostate Cancer—A Review of Current Therapies and Future Promise

    Treatment of Advanced Prostate Cancer—A Review of Current Therapies and Future Promise od Semini Sumanasuriya, Johann S. de Bono

    Wydane 2017
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  3. 3
    Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break?

    Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break? od Gerhardt Attard, Colin S. Cooper, Johann S. de Bono

    Wydane 2009
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  4. 4
    New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway

    New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway od Gerhardt Attard, Juliet Richards, Johann S. de Bono

    Wydane 2011
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  5. 5
    CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer

    CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer od Joo Ern Ang, David Olmos, Johann S. de Bono

    Wydane 2009
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  6. 6
    Antitumor Activity with CYP17 Blockade Indicates That Castration-Resistant Prostate Cancer Frequently Remains Hormone Driven

    Antitumor Activity with CYP17 Blockade Indicates That Castration-Resistant Prostate Cancer Frequently Remains Hormone Driven od Gerhardt Attard, Alison Reid, David Olmos, Johann S. de Bono

    Wydane 2009
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  7. 7
    The promise of circulating tumor cell analysis in cancer management

    The promise of circulating tumor cell analysis in cancer management od Joaquı́n Mateo, Marco Gerlinger, Daniel Nava Rodrigues, Johann S. de Bono

    Wydane 2014
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  8. 8
    Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer

    Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer od Debashis Sarker, Alison Reid, Timothy A. Yap, Johann S. de Bono

    Wydane 2009
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  9. 9
    Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

    Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic od Timothy A. Yap, Shahneen Sandhu, Craig P. Carden, Johann S. de Bono

    Wydane 2011
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  10. 10
    Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects

    Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects od Roberta Ferraldeschi, Jonathan Welti, Jun Luo, Gerhardt Attard, Johann S. de Bono

    Wydane 2014
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  11. 11
    Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics

    Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics od Deborah Mukherji, Aurelius Omlin, Carmel Pezaro, Ali Shamseddine, Johann S. de Bono

    Wydane 2014
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  12. 12
    Second-line treatment options in metastatic castration-resistant prostate cancer: A comparison of key trials with recently approved agents

    Second-line treatment options in metastatic castration-resistant prostate cancer: A comparison of key trials with recently approved agents od Amit Bahl, Susan Masson, Alison Birtle, Simon Chowdhury, Johann S. de Bono

    Wydane 2013
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  13. 13
    Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function

    Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function od Felix Y. Feng, Johann S. de Bono, Mark A. Rubin, Karen E. Knudsen

    Wydane 2015
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  14. 14
    Circulating Tumor Cells: A Multifunctional Biomarker

    Circulating Tumor Cells: A Multifunctional Biomarker od Timothy A. Yap, David Lorente, Aurelius Omlin, David Olmos, Johann S. de Bono

    Wydane 2014
    Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  15. 15
    Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician

    Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician od Stéphanie Lheureux, Christophe Denoyelle, Pamela S. Ohashi, Johann S. de Bono, Felix M. Mottaghy

    Wydane 2017
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  16. 16
    Improving the outcome of patients with castration-resistant prostate cancer through rational drug development

    Improving the outcome of patients with castration-resistant prostate cancer through rational drug development od Gerhardt Attard, Debashis Sarker, Alison Reid, R. Molife, Chris Parker, Johann S. de Bono

    Wydane 2006
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  17. 17
    Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications

    Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications od Beshara Sheehan, Christina Guo, Antje Neeb, Alec Paschalis, Shahneen Sandhu, Johann S. de Bono

    Wydane 2021
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  18. 18
    Enzalutamide in castration‐resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trial

    Enzalutamide in castration‐resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trial od Yohann Loriot, Karim Fizazi, Johann S. de Bono, David Forer, Mohammad Hirmand, Howard I. Scher

    Wydane 2016
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  19. 19
    Therapy monitoring of skeletal metastases with whole-body diffusion MRI

    Therapy monitoring of skeletal metastases with whole-body diffusion MRI od Anwar R. Padhani, Andreas Makris, Peter Gall, David J. Collins, Nina Tunariu, Johann S. de Bono

    Wydane 2014
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  20. 20
    Clinical anticancer drug development: targeting the cyclin-dependent kinases

    Clinical anticancer drug development: targeting the cyclin-dependent kinases od Charlotte Benson, S.B. Kaye, Paul Workman, Michelle D. Garrett, Michael Walton, Johann S. de Bono

    Wydane 2004
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:

Narzędzie wyszukiwania: